TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment Options for PMF
Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Primary Myelofibrosis
Treatment options for PMF include:
Clinical trials involving other JAK2 inhibitors.
Pomalidomide.[36]
Source links and citations
Splenic radiation therapy or radiation to sites of symptomatic extramedullary hematopoiesis (e.g., large lymph nodes, cord compression).[7]
Source links and citations
Cladribine.[52]
Source links and citations
Continue within this section
Publication references
Read the original reference and check its publication notices.
- PubMed 10216077 · Original source
- PubMed 10561375 · Original source
- PubMed 10733489 · Original source
- PubMed 10781623 · Original source
- PubMed 12613516 · Original source
- PubMed 12920019 · Original source
- PubMed 16583431 · Original source
- PubMed 16609064 · Original source
- PubMed 17460705 · Original source
- PubMed 19720904 · Original source
- PubMed 21052089 · Original source
- PubMed 21220594 · Original source
- PubMed 21552298 · Original source
- PubMed 21622644 · Original source
- PubMed 22375970 · Original source
- PubMed 8574158 · Original source
- PubMed 9375753 · Original source
- PubMed 9572998 · Original source
- PubMed 9740087 · Original source
Preserved source evidence · Not medical advice